NDC 71209-102
Erythromycin ethylsuccinate 200 mg per 5 mL for suspension
On the label: Cadila Pharmaceuticals Limited.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Cadila Pharmaceuticals Limited | Ahmedabad, India | Makes it, tests it, packages it and labels it | No problems foundSep 26, 2025 · 7 inspections |
Product details
- Generic drug
- Erythromycin: every company that makes it
- Form
- for suspension, oral
- Strength
- 200 mg per 5 mL
- Approval
- ANDA ANDA216212
- On the market since
- Nov 21, 2022
- Package NDCs
71209-102-21- Official label
- DailyMed (National Library of Medicine), updated Nov 11, 2023
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?